title: Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis.
authors.forename: M
authors.initials: M
authors.lastname: Friedrich
authors.forename: W
authors.initials: W
authors.lastname: Sterry
authors.forename: A
authors.initials: A
authors.lastname: Klein
authors.forename: R
authors.initials: R
authors.lastname: Rückert
authors.forename: W D
authors.initials: WD
authors.lastname: Döcke
authors.forename: K
authors.initials: K
authors.lastname: Asadullah
mesh_terms: D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003967:Diarrhea / Q000139:chemically induced / Q000517:prevention & control; D000069462:Dimethyl Fumarate; D005260:Female; D005483:Flushing / Q000139:chemically induced / Q000517:prevention & control; D005650:Fumarates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage*; D011446:Prospective Studies; D011565:Psoriasis / Q000188:drug therapy* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D003879:Dermatologic Agents; D005650:Fumarates; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069462:Dimethyl Fumarate; D010431:Pentoxifylline